SLC7A11 and non-small cell lung carcinoma: When SLC7A11 is overexpressed in normal airway epithelial cells, there is an increased glutamine dependence, reduced ROS production, and subsequent ferroptosis suppression, which correlates with a predicted decline in the 5-year survival rate for NSCLC patients (18).